ProfileGDS4718 / 219079_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 85% 72% 88% 87% 78% 80% 87% 84% 87% 90% 82% 85% 82% 79% 84% 88% 80% 73% 65% 87% 86% 89% 89% 85% 81% 83% 66% 85% 75% 75% 78% 82% 90% 77% 84% 78% 83% 86% 78% 88% 78% 69% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.653386
GSM549102patient 115, normal, homogenized [OPG study]8.3852485
GSM549104patient 119, normal, homogenized [OPG study]7.137172
GSM549108patient 138, normal, homogenized [OPG study]8.8559288
GSM549119patient 077, normal, homogenized [OPG study]8.6800287
GSM549133patient 032, cancer, homogenized [OPG study]7.7807178
GSM549139patient 042, cancer, homogenized [OPG study]7.836180
GSM549099patient 107, normal, homogenized [OPG study]8.6915687
GSM549109patient 139, normal, homogenized [OPG study]8.3196384
GSM549110patient 046, normal, homogenized [OPG study]8.7966287
GSM549114patient 063, normal, homogenized [OPG study]9.3399790
GSM549122patient 082, normal, homogenized [OPG study]8.0372182
GSM549134patient 033, cancer, homogenized [OPG study]8.554185
GSM549136patient 036, cancer, homogenized [OPG study]8.2456382
GSM549140patient 044, cancer, homogenized [OPG study]7.7838879
GSM549111patient 047, normal, homogenized [OPG study]8.4721884
GSM549113patient 057, normal, homogenized [OPG study]9.1214888
GSM549132patient 031, cancer, homogenized [OPG study]7.9057280
GSM549137patient 038, cancer, homogenized [OPG study]7.2205373
GSM549142patient 047, cancer, homogenized [OPG study]6.4957265
GSM549100patient 110, normal, homogenized [OPG study]8.6654887
GSM549107patient 135, normal, homogenized [OPG study]8.5839786
GSM549115patient 068, normal, homogenized [OPG study]9.2655889
GSM549116patient 072, normal, homogenized [OPG study]9.1774789
GSM549120patient 078, normal, homogenized [OPG study]8.4331985
GSM549131patient 030, cancer, homogenized [OPG study]8.1366681
GSM549118patient 074, normal, homogenized [OPG study]8.2415783
GSM549129patient 027, cancer, homogenized [OPG study]6.6108866
GSM549123patient 088, normal, homogenized [OPG study]8.4979485
GSM549124patient 006, cancer, homogenized [OPG study]7.2831575
GSM549126patient 015, cancer, homogenized [OPG study]7.3002875
GSM549128patient 025, cancer, homogenized [OPG study]7.7565278
GSM549103patient 117, normal, homogenized [OPG study]8.004482
GSM549117patient 073, normal, homogenized [OPG study]9.2934190
GSM549138patient 041, cancer, homogenized [OPG study]7.5258377
GSM549141patient 045, cancer, homogenized [OPG study]8.3876484
GSM549130patient 028, cancer, homogenized [OPG study]7.6589278
GSM549101patient 111, normal, homogenized [OPG study]8.1579583
GSM549105patient 128, normal, homogenized [OPG study]8.5164586
GSM549106patient 134, normal, homogenized [OPG study]7.7927578
GSM549112patient 048, normal, homogenized [OPG study]8.9371588
GSM549125patient 011, cancer, homogenized [OPG study]7.5928678
GSM549127patient 024, cancer, homogenized [OPG study]6.8846669
GSM549135patient 035, cancer, homogenized [OPG study]7.5470676